Truvestments Capital’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $316K | Sell |
1,613
-226
| -12% | -$43.9K | 0.06% | 255 |
|
|
2025
Q4 | $319K | Buy |
1,839
+5
| +0.3% | +$910 | 0.06% | 242 |
|
|
2025
Q3 | $350K | Sell |
1,834
-66
| -3% | -$11.7K | 0.06% | 230 |
|
|
2025
Q2 | $341K | Sell |
1,900
-18
| -0.9% | -$3.13K | 0.07% | 195 |
|
|
2025
Q1 | $324K | Sell |
1,918
-510
| -21% | -$83.8K | 0.07% | 190 |
|
|
2024
Q4 | $366K | Sell |
2,428
-86
| -3% | -$13.4K | 0.09% | 162 |
|
|
2024
Q3 | $390K | Buy |
+2,514
| New | +$375K | 0.1% | 152 |
|
|
2024
Q2 | – | Sell |
-1,160
| Closed | -$154K | – | 348 |
|
|
2024
Q1 | $154K | Sell |
1,160
-5,953
| -84% | -$772K | 0.06% | 255 |
|
|
2023
Q4 | $981K | Sell |
7,113
-1,980
| -22% | -$260K | 0.44% | 59 |
|
|
2023
Q3 | $1.11M | Sell |
9,093
-547
| -6% | -$72.9K | 0.58% | 57 |
|
|
2023
Q2 | $1.35M | Sell |
9,640
-431
| -4% | -$59.4K | 0.67% | 56 |
|
|
2023
Q1 | $1.42M | Buy |
10,071
+586
| +6% | +$83.8K | 0.76% | 56 |
|
|
2022
Q4 | $1.48M | Buy |
9,485
+7,878
| +490% | +$1.13M | 0.84% | 47 |
|
|
2022
Q3 | $197K | Buy |
1,607
+4
| +0.2% | +$527 | 0.12% | 142 |
|
|
2022
Q2 | $213K | Sell |
1,603
-53
| -3% | -$7.22K | 0.12% | 149 |
|
|
2022
Q1 | $227K | Buy |
1,656
+4
| +0.2% | +$558 | 0.12% | 159 |
|
|
2021
Q4 | $286K | Buy |
1,652
+118
| +8% | +$18K | 0.14% | 135 |
|
|
2021
Q3 | $223K | Buy |
1,534
+21
| +1% | +$3.07K | 0.12% | 147 |
|
|
2021
Q2 | $200K | Buy |
1,513
+148
| +11% | +$19.4K | 0.11% | 148 |
|
|
2021
Q1 | $175K | Buy |
1,365
+377
| +38% | +$46.5K | 0.1% | 164 |
|
|
2020
Q4 | $117K | Buy |
+988
| New | +$120K | 0.08% | 180 |
|
|
2020
Q3 | – | Sell |
-867
| Closed | -$98K | – | 377 |
|
|
2020
Q2 | $98K | Sell |
867
-189
| -18% | -$20K | 0.1% | 154 |
|
|
2020
Q1 | $84K | Sell |
1,056
-5,286
| -83% | -$547K | 0.11% | 133 |
|
|
2019
Q4 | $677K | Sell |
6,342
-128
| -2% | -$13.3K | 0.47% | 70 |
|
|
2019
Q3 | $693K | Sell |
6,470
-251
| -4% | -$25.8K | 0.45% | 66 |
|
|
2019
Q2 | $684K | Buy |
6,721
+2,561
| +62% | +$246K | 0.46% | 62 |
|
|
2019
Q1 | $374K | Buy |
+4,160
| New | +$360K | 0.29% | 79 |
|
|
2018
Q3 | $385K | Buy |
3,568
+95
| +3% | +$10.4K | 0.19% | 121 |
|
|
2018
Q2 | $382K | Buy |
+3,473
| New | +$362K | 0.24% | 111 |
|
Other funds holding DGX
VCM
VPM
EIG
Truvestments Capital's DGX Position: Q1 2026 in Review
Truvestments Capital reduced its Quest Diagnostics (DGX) stake by 12% in Q1 2026, selling an estimated $43.9K and leaving 1,613 shares worth $316K. The position accounts for 0.06% of the portfolio, ranked #255.
Truvestments Capital first reported a position in DGX in Q2 2018 and has held it in 29 quarters since. The position peaked at $1.48M in Q4 2022. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Truvestments Capital held 1,613 shares of Quest Diagnostics worth $316K as of Q1 2026.
- Truvestments Capital sold 226 Quest Diagnostics shares in Q1 2026, an estimated $43.9K.
- Quest Diagnostics made up 0.06% of Truvestments Capital's portfolio in Q1 2026, its #255 holding.
- Truvestments Capital first reported a position in Quest Diagnostics in Q2 2018 and has held it in 29 quarters since.
- Truvestments Capital's Quest Diagnostics position peaked at $1.48M in Q4 2022.
- 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.